SS Innovations names Sarah M. Romano as CFO, effective August 3

SS Innovations International, Inc. (NASDAQ: SSII), a surgical robotics company, announced the appointment of Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano will be based in the United States, according to a company press release.

Romano brings more than two decades of finance experience in the medical technology and life sciences sectors. She most recently served as CFO of Vicarious Surgical, a robotic surgery company, where she led efforts to reduce cash burn and strengthen the balance sheet. Prior to that role, she served as CFO of Entero Therapeutics and Kiora Pharmaceuticals, where she oversaw capital raising, SEC reporting, and investor relations. Throughout her career, Romano has raised more than $100 million through public and private financings.

Romano began her career as an auditor at PricewaterhouseCoopers and holds a licensed Certified Public Accountant designation in Massachusetts. She earned a Bachelor of Arts in Accounting from the College of the Holy Cross and a Master of Accountancy from Boston College.

Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, said, "As we continue our global expansion, including pursuing U.S. FDA approval of our advanced, cost-effective SSi Mantra surgical robotic system, Sarah brings strong financial leadership, keen strategic vision, and extensive capital markets experience."

SS Innovations develops surgical robotic systems, including its SSi Mantra platform, and is headquartered in India with U.S. operations based in Fort Lauderdale, Florida.

You May Also Be Interested In

• SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
• IPG Photonics to acquire Lumibird Medical for up to €350M
• Powerus subsidiary advances to Phase 3 of U.S. Army xTech competition